You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Immunol., 17 October 2022

Sec. Immunological Tolerance and Regulation

Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1043240

Corrigendum: IL36G is associated with cutaneous antiviral competence in psoriasis

  • 1. Department of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China

  • 2. Hubei Provincial Key Laboratory of Occurrence and Intervention of Kidney Diseases, Medical College, Hubei Polytechnic University, Huangshi, China

  • 3. Department of Dermatology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, Huangshi, China

  • 4. NHC Key Laboratory of Drug Addiction Medicine, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, China

  • 5. Scientific Research Laboratory Center, First Affiliated Hospital of Kunming Medical University, Kunming, China

Article metrics

View details

986

Views

649

Downloads

In the published article, there was an error in the author list. You-Wang Lu and Yong-Jun Chen contributed equally to this work and share first authorship. The corrected author list appears below.

You-Wang Lu 1,2†, Yong-Jun Chen 3†, Nian Shi 3, Lu-Hui Yang 1, Hong-Mei Wang 1, Rong-Jing Dong 1,2,3*, Yi-Qun Kuang 4,5*, and Yu-Ye Li 1*

†These authors have contributed equally to this work and share first authorship

In the published article, there is an error in the title. Instead of “L36G is associated with cutaneous antiviral competence in psoriasis”, it should be “IL36G is associated with cutaneous antiviral competence in psoriasis”.

The authors state that these errors do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

psoriasis, antiviral protein (AVP), IL36G, keratinocyte, treatment

Citation

Lu Y-W, Chen Y-J, Shi N, Yang L-H, Wang H-M, Dong R-J, Kuang Y-Q and Li Y-Y (2022) Corrigendum: IL36G is associated with cutaneous antiviral competence in psoriasis. Front. Immunol. 13:1043240. doi: 10.3389/fimmu.2022.1043240

Received

13 September 2022

Accepted

05 October 2022

Published

17 October 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Rong-Jing Dong, ; Yi-Qun Kuang, ; Yu-Ye Li,

†These authors have contributed equally to this work and share first authorship

This article was submitted to Immunological Tolerance and Regulation, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics